Two more drug companies to officially launch on TrumpRx
Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted pharmaceutical site as soon ...
Last updated: 2026-04-07 09:14:07 ET
Pulse AI Brief
Updated Apr 7, 2026 9:05 AM ET
Healthcare stocks are rallying sharply on news that expected Medicare Advantage payment rates for 2027 are rising, signaling stronger reimbursement tailwinds for insurers and providers. UnitedHealth and other major healthcare names are among the biggest premarket movers.
Higher Medicare Advantage rates directly improve margins for UnitedHealth, Anthem, Humana, and regional insurers. This removes a key headwind that had pressured healthcare valuations and could unlock rapid profit growth across the sector, particularly for companies with high MA exposure.
Stronger payment rates reduce political risk around healthcare policy and suggest the administration is not pursuing aggressive cost-cutting measures. This stabilizes earnings visibility for a sector that had faced uncertainty around reimbursement pressure.
Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted pharmaceutical site as soon ...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE